Aleafia Health Announces TSX Decision to Extend Delisting Review Period to November 29, 2022

Rhea-AI Summary

Aleafia Health has announced that the Toronto Stock Exchange has extended its delisting review period until November 29, 2022. This decision follows previous announcements regarding the company's status. Aleafia Health provides cannabis products in both Canadian adult-use and medical markets and operates a virtual medical cannabis clinic to offer health services across Canada. The company aims to keep stakeholders updated on future developments.

Positive

• Delisting review extended until November 29, 2022, providing additional time for resolution.

Negative

• Continued delisting review may indicate ongoing financial or operational challenges.

TORONTO, Sept. 16, 2022 (GLOBE NEWSWIRE) -- Further to its previous announcements, Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) announces that the Toronto Stock Exchange (“TSX”) issued a decision today to extend its delisting review period until November 29, 2022. The Company will provide further updates as warranted.

For Investor & Media Relations:

Matthew Sale, CFO
1-833-879-2533
IR@AleafiaHealth.com
LEARN MORE: www.AleafiaHealth.com

About Aleafia Health:

The Company is a federally licensed Canadian cannabis company offering cannabis products in Canadian adult-use and medical markets and in select international markets, including Australia and Germany. The Company operates a virtual medical cannabis clinic staffed by physicians and nurse practitioners which provide health and wellness services across Canada.

FAQ

Why has Aleafia Health delayed its delisting from the Toronto Stock Exchange?

The Toronto Stock Exchange has extended Aleafia Health's delisting review period until November 29, 2022, suggesting the company is still addressing concerns.

What does the delisting review extension mean for Aleafia Health investors?

The extension indicates that Aleafia Health has more time to address the issues raised by the TSX, which could impact investor confidence.

What is Aleafia Health's business focus?

Aleafia Health is focused on providing cannabis products in Canadian adult-use and medical markets, as well as offering health services through a virtual cannabis clinic.